Partner Harvey Kesner Represents MabVax Therapeutics Holdings, Inc. in a Debt Facility for up to $10,000,000

mabvax therapeutics

Press Release – New York, NY – January 21, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm represented MabVax Therapeutics Holdings, Inc. in connection with a debt facility for up to $10,000,000 of which the Company has received $5,000,000. The company focuses on developing vaccine antibody-based therapeutics for the diagnosis and treatment of cancer. The Sichenzia Ross Friedman Ference LLP team was led by Harvey Kesner, David Manno and Tara Guarneri-Ferrara.

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP

Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

Visit SRFK's LinkedIn page
Sichenzia Ross Ference Kesner LLP